Aromatherapy and Music on Sleep and Children With Epilepsy
The Effects of Aromatherapy and Music Listening on Sleep and Cerebral Oxygen Levels in Children With Epilepsy
1 other identifier
interventional
90
1 country
1
Brief Summary
Purpose: This study aimed to compare the effects of aromatherapy and music listening with routine care on sleep parameters and cerebral oxygenation in children with epilepsy. Design and methods: This randomized controlled experimental study was conducted between February and December 2023 with children diagnosed with epilepsy living in Malatya Province and surrounding regions. The sample consisted of 90 children allocated to aromatherapy (n = 30), music listening (n = 30), and control (n = 30) groups. Children in the intervention groups received aromatherapy or music listening, whereas the control group received routine care only. Data were collected using the Patient Introduction and Follow-up Form, actigraphy, and the Cerebral Oxygen Monitoring Form. One-way ANOVA, Kruskal-Wallis, chi-square, Mann-Whitney U, LSD, and Dunnett's C tests were used for data analysis. Results: Aromatherapy was associated with higher cerebral oxygen levels, longer time spent in bed, longer sleep duration, higher sleep efficiency, and lower sleep onset latency (p \< 0.05). Similarly, music listening was associated with higher cerebral oxygen levels, longer sleep duration, and higher sleep efficiency (p \< 0.05). Conclusion: Aromatherapy and music listening may improve selected sleep parameters and cerebral oxygenation in children with epilepsy. Practice implications: Aromatherapy and music listening may be considered supportive, non-pharmacological interventions for improving sleep and cerebral oxygenation in pediatric epilepsy care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 28, 2023
CompletedFirst Submitted
Initial submission to the registry
September 11, 2026
CompletedFirst Posted
Study publicly available on registry
September 18, 2026
CompletedSeptember 18, 2026
September 1, 2026
7 months
September 11, 2026
September 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Time Spent in Bed
Time spent in bed was objectively assessed using the Actiwatch 2 actigraphy device and Actiware 6 software. It represents the total time the child spent in bed during the monitored sleep period and was expressed in hours.
24-hour actigraphy monitoring period
Awakening Time During Sleep
Awakening time during sleep was objectively assessed using the Actiwatch 2 actigraphy device and Actiware 6 software. It represents the total duration of wakefulness occurring after sleep onset and before the end of the sleep period and was expressed in
24-hour actigraphy monitoring period
Number of Awakenings During Sleep
The number of awakenings during sleep was objectively assessed using the Actiwatch 2 actigraphy device and Actiware 6 software. It represents the number of episodes scored as wakefulness occurring during the monitored sleep period and was reported as a count.
24-hour actigraphy monitoring period
Sleep Duration
Sleep duration was objectively assessed using the Actiwatch 2 actigraphy device and Actiware 6 software. It represents the total amount of time scored as sleep during the monitored sleep period and was expressed in hours.
24-hour actigraphy monitoring period
Sleep Onset Latency
Sleep onset latency was objectively assessed using the Actiwatch 2 actigraphy device and Actiware 6 software. It represents the time from the beginning of the sleep period to sleep onset and was expressed in minutes.
24-hour actigraphy monitoring period
Sleep Efficiency
Sleep efficiency was objectively assessed using the Actiwatch 2 actigraphy device and Actiware 6 software. It represents the percentage of time spent asleep relative to the total time spent in bed during the monitored sleep period and was expressed as a percentage (%).
24-hour actigraphy monitoring period
Regional Cerebral Oxygen Saturation (rSO₂)
Regional cerebral oxygen saturation (rSO₂) was assessed noninvasively using near-infrared spectroscopy (NIRS) with the INVOS 5100C system and compatible INVOS pediatric sensors. rSO₂ values were recorded at 30, 60, 90, 120, and 150 minutes during the monitoring period. The five measurements were averaged to obtain one mean rSO₂ value for each participant. Regional cerebral oxygen saturation was expressed as a percentage (%).
150-minute NIRS monitoring period
Study Arms (3)
Aromatherapy Group
EXPERIMENTALBefore evening sleep, lavender aromatherapy was administered by inhalation for 30 minutes using a scented pillow. NIRS monitoring was initiated concurrently with the 30-minute aromatherapy intervention and continued for a total of 150 minutes.
Music Listening Group
EXPERIMENTALBefore evening sleep, music selected by the child or parent was played at 45-65 dB for 30 minutes. NIRS monitoring was initiated concurrently with the 30-minute music-listening intervention and continued for a total of 150 minutes.
Control Group
NO INTERVENTIONRoutine care only
Interventions
Lavender aromatherapy administered by inhalation using a scented pillow
Eligibility Criteria
You may qualify if:
- Generalized tonic-clonic seizure,
- Children who take at least one antiepileptic drug.
You may not qualify if:
- Children with hearing problems,
- Children with resistant epilepsy,
- Children diagnosed with sleep disorders,
- Children diagnosed with neurological, psychiatric, or medical disorders other than epilepsy,
- Children with allergies,
- Children with impaired sense of smell,
- Children whose parents did not give consent were excluded from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kafkas Universitylead
- Inonu Universitycollaborator
Study Sites (1)
İnönü University Turgut Özal Medical Center
Malatya, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Emriye Hilal Yayan, Prof. Dr.
Department of Child Health Nursing Faculty of Nursing, Inonu University, 44280 Malatya, Türkiye
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
September 11, 2026
First Posted
September 18, 2026
Study Start
February 1, 2023
Primary Completion
August 15, 2023
Study Completion
December 28, 2023
Last Updated
September 18, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share